Issue Information.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 455, doi. 10.1002/jca.21581
- Publication type:
- Article
Works matching IS 07332459 AND DT 2018 AND VI 33 AND IP 4
Results: 15
1
2
Depletion of αβ<sup>+</sup> T cells for a haploidentical hematopoietic stem cell transplantation in children.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 521, doi. 10.1002/jca.21634
- By:
- Publication type:
- Article
3
The definition of severe systemic lupus erythematosus needs clarification in the next ASFA guidelines.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 551, doi. 10.1002/jca.21635
- By:
- Publication type:
- Article
4
Extracorporeal photopheresis and personalized medicine in the 21st century: The future's so bright!
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 461, doi. 10.1002/jca.21633
- By:
- Publication type:
- Article
5
Efficacy and safety of granulocyte adsorption apheresis in elderly patients with ulcerative colitis.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 514, doi. 10.1002/jca.21631
- By:
- Publication type:
- Article
6
Therapeutic plasma exchange: Experience in a third level hospital, 2013–2016, Lima (Peru).
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 480, doi. 10.1002/jca.21623
- By:
- Publication type:
- Article
7
Optia® continuous mononuclear collection (CMNC) system is a safe and efficient system for hematopoietic progenitor cells‐apheresis (HPC‐a) collection and yields a lower product hematocrit (HCT%) than the COBE® spectra system: A retrospective study
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 505, doi. 10.1002/jca.21629
- By:
- Publication type:
- Article
8
The use of cytapheresis in the treatment of infectious diseases.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 529, doi. 10.1002/jca.21620
- By:
- Publication type:
- Article
9
Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low‐density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 546, doi. 10.1002/jca.21632
- By:
- Publication type:
- Article
10
American council on ECP (ACE): Why now?
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 464, doi. 10.1002/jca.21627
- By:
- Publication type:
- Article
11
Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 469, doi. 10.1002/jca.21622
- By:
- Publication type:
- Article
12
Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): Could this be a new predictive biomarker in TTP?
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 541, doi. 10.1002/jca.21621
- By:
- Publication type:
- Article
13
Anticoagulation, bleeding, and clotting at donor plasmapheresis.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 538, doi. 10.1002/jca.21626
- By:
- Publication type:
- Article
14
Impact of apheresis automation on procedure quality and predictability of CD34<sup>+</sup> cell yield.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 494, doi. 10.1002/jca.21625
- By:
- Publication type:
- Article
15
The effects of galectin‐3 depletion apheresis on induced skin inflammation in a porcine model.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 4, p. 486, doi. 10.1002/jca.21624
- By:
- Publication type:
- Article